Literature DB >> 11486094

Seasonal distribution of antiphospholipid antibodies.

T H Luong1, J H Rand, X X Wu, J H Godbold, M Gascon-Lema, S Tuhrim.   

Abstract

BACKGROUND AND
PURPOSE: The purpose of this study was to determine if there was a seasonal variation in antiphospholipid antibody (aPL) titers and whether this variation differed between stroke cases and control subjects.
METHODS: IgG and IgM anticardiolipin and antiphosphatidyl serine antibody titers were obtained on serum samples from 884 stroke patients and 1024 control subjects over a 7-year period. Temporal distributions by month of blood draw were evaluated.
RESULTS: Marked seasonal differences in the proportion of positive titers were found for control subjects, but no seasonal variability among patients was noted. In control subjects, positive titers occurred less frequently in the summer months, mirroring the seasonal trends seen in respiratory track infections and rheumatic fever.
CONCLUSIONS: Our data suggest some aPL antibodies arise from different origins in patients and control subjects. The seasonality observed in the apparently normal population may be related to antibodies of infectious origin and is consistent with the reported lack of association with thrombosis of infection-related antibodies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11486094     DOI: 10.1161/01.str.32.8.1707

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Seasonal variation in the activity of systemic lupus erythematosus.

Authors:  Alí Duarte-García; Hong Fang; Chi Hung To; Laurence S Magder; Michelle Petri
Journal:  J Rheumatol       Date:  2012-06-01       Impact factor: 4.666

Review 2.  Antiphospholipid antibodies and stroke.

Authors:  Stanley Tuhrim
Journal:  Curr Cardiol Rep       Date:  2004-03       Impact factor: 2.931

3.  Stroke in Patients with Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome.

Authors:  Claudia J. Chaves
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

Review 4.  Antiphospholipid antibodies in response to infection.

Authors:  Tadej Avcin; Natasa Toplak
Journal:  Curr Rheumatol Rep       Date:  2007-06       Impact factor: 4.686

Review 5.  Perspective: Vitamin D deficiency and COVID-19 severity - plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2 and thrombosis.

Authors:  J M Rhodes; S Subramanian; E Laird; G Griffin; R A Kenny
Journal:  J Intern Med       Date:  2020-07-22       Impact factor: 13.068

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.